Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 11, 2021, titled "Sun Pharma geared to introduce Molnupiravir, licensed from MSD and Ridgeback, under the brand name Molxvir�� in India".
Press Release Nov 11 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Nov 02 2021
- Press Release Nov 01 2021
- Press Release Oct 28 2021
- Press Release Oct 19 2021
- Press Release Sep 28 2021
Later from Sun Pharmaceutical Industries
- Press Release Dec 15 2021
- Press Release Dec 28 2021
- Press Release Jan 18 2022
- Sun Pharmaceutical Industries: Dividend Updates
- Press Release Jan 27 2022
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries